T. Rowe Price Associates’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.67M Buy
100,477
+11,456
+13% +$826K ﹤0.01% 1283
2025
Q4
$5.68M Sell
89,021
-79,294
-47% -$4.89M ﹤0.01% 1351
2025
Q3
$10.6M Buy
168,315
+1,437
+0.9% +$100K ﹤0.01% 1215
2025
Q2
$12.5M Buy
166,878
+334
+0.2% +$26.2K ﹤0.01% 1071
2025
Q1
$14.7M Buy
166,544
+1,468
+0.9% +$139K ﹤0.01% 1029
2024
Q4
$15.1M Sell
165,076
-26
-0% -$2.67K ﹤0.01% 1049
2024
Q3
$18.5M Buy
165,102
+2,659
+2% +$266K ﹤0.01% 1010
2024
Q2
$15.9M Buy
162,443
+2,969
+2% +$295K ﹤0.01% 1014
2024
Q1
$16M Buy
159,474
+750
+0.5% +$66K ﹤0.01% 1028
2023
Q4
$14.3M Sell
158,724
-1
-0% -$80 ﹤0.01% 1028
2023
Q3
$12.2M Buy
158,725
+372
+0.2% +$30.9K ﹤0.01% 1033
2023
Q2
$13.3M Sell
158,353
-713,735
-82% -$58M ﹤0.01% 1030
2023
Q1
$73.6M Buy
872,088
+713,832
+451% +$61.3M 0.01% 583
2022
Q4
$12.9M Sell
158,256
-7,645
-5% -$616K ﹤0.01% 1012
2022
Q3
$11.8M Buy
165,901
+1
+0% +$90 ﹤0.01% 1037
2022
Q2
$14.9M Sell
165,900
-17,738
-10% -$1.84M ﹤0.01% 1242
2022
Q1
$20.6M Sell
183,638
-16,731
-8% -$1.96M ﹤0.01% 1226
2021
Q4
$24.2M Sell
200,369
-10,294
-5% -$1.14M ﹤0.01% 1237
2021
Q3
$21.2M Sell
210,663
-1,212,674
-85% -$134M ﹤0.01% 1280
2021
Q2
$166M Buy
1,423,337
+1,209,167
+565% +$145M 0.02% 618
2021
Q1
$23.6M Sell
214,170
-18,150
-8% -$1.97M ﹤0.01% 1238
2020
Q4
$23.3M Sell
232,320
-10,759
-4% -$998K ﹤0.01% 1186
2020
Q3
$19M Sell
243,079
-8,581
-3% -$647K ﹤0.01% 1169
2020
Q2
$17.5M Sell
251,660
-19,809
-7% -$1.25M ﹤0.01% 1177
2020
Q1
$12.6M Sell
271,469
-3,005,553
-92% -$193M ﹤0.01% 1189
2019
Q4
$260M Buy
3,277,022
+3,028,240
+1,217% +$233M 0.03% 428
2019
Q3
$18.4M Sell
248,782
-6,911
-3% -$496K ﹤0.01% 1180
2019
Q2
$19.9M Buy
255,693
+151
+0.1% +$11.5K ﹤0.01% 1178
2019
Q1
$19.4M Buy
255,542
+8,240
+3% +$655K ﹤0.01% 1177
2018
Q4
$18.1M Buy
247,302
+1,120
+0.5% +$89.3K ﹤0.01% 1177
2018
Q3
$23.6M Buy
246,182
+138
+0.1% +$13.7K ﹤0.01% 1168
2018
Q2
$24.6M Buy
246,044
+80
+0% +$8.45K ﹤0.01% 1135
2018
Q1
$26M Sell
245,964
-1,060
-0.4% -$107K ﹤0.01% 1095
2017
Q4
$22.9M Sell
247,024
-1,388,564
-85% -$126M ﹤0.01% 1143
2017
Q3
$148M Buy
1,635,588
+1,364,154
+503% +$116M 0.03% 511
2017
Q2
$22.8M Buy
271,434
+1,522
+0.6% +$123K ﹤0.01% 1122
2017
Q1
$21.8M Sell
269,912
-5,670
-2% -$446K ﹤0.01% 1123
2016
Q4
$20.7M Buy
275,582
+80
+0% +$5.78K ﹤0.01% 1133
2016
Q3
$18.6M Buy
275,502
+3,423
+1% +$230K ﹤0.01% 1158
2016
Q2
$18.5M Sell
272,079
-1,658
-0.6% -$122K ﹤0.01% 1127
2016
Q1
$19.8M Buy
273,737
+17,091
+7% +$1.12M ﹤0.01% 1080
2015
Q4
$17.3M Sell
256,646
-18,100
-7% -$1.27M ﹤0.01% 1130
2015
Q3
$17.8M Buy
274,746
+15,400
+6% +$1.14M ﹤0.01% 1131
2015
Q2
$21.2M Buy
259,346
+1,532
+0.6% +$118K ﹤0.01% 1123
2015
Q1
$17.9M Buy
257,814
+1,800
+0.7% +$130K ﹤0.01% 1171
2014
Q4
$19.4M Buy
256,014
+14,100
+6% +$1.11M ﹤0.01% 1120
2014
Q3
$19.6M Buy
241,914
+5,200
+2% +$434K ﹤0.01% 1124
2014
Q2
$20.7M Sell
236,714
-100
-0% -$8.69K ﹤0.01% 1111
2014
Q1
$20.4M Buy
236,814
+4,600
+2% +$377K ﹤0.01% 1100
2013
Q4
$18.7M Sell
232,214
-3,890
-2% -$302K ﹤0.01% 1110
2013
Q3
$18.4M Sell
236,104
-2,110
-0.9% -$163K ﹤0.01% 1106
2013
Q2
$16.7M Buy
+238,214
New +$16.6M ﹤0.01% 1117

Other funds holding EMN

T. Rowe Price Associates's EMN Position: Q1 2026 in Review

T. Rowe Price Associates increased its Eastman Chemical (EMN) stake by 13% in Q1 2026, buying an estimated $826K and bringing the position to 100,477 shares worth $7.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1283.

T. Rowe Price Associates first reported a position in EMN in Q2 2013 and has held it in 52 quarters since. The position peaked at $260M in Q4 2019. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • T. Rowe Price Associates held 100,477 shares of Eastman Chemical worth $7.67M as of Q1 2026.
  • T. Rowe Price Associates bought 11,456 Eastman Chemical shares in Q1 2026, an estimated $826K.
  • Eastman Chemical made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1283 holding.
  • T. Rowe Price Associates first reported a position in Eastman Chemical in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Eastman Chemical position peaked at $260M in Q4 2019.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.